SCHEMBL3034655

SCHEMBL3034655

NC(=O)c1ccc(-c2cccc(C(=O)N(O)Cc3cccc(C(F)(F)F)c3)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.52
TRPM8 Q7Z2W7 1/20 0.49
GPR52 Q9Y2T5 1/20 0.48
HDAC6 Q9UBN7 2/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
AOC3 Q16853 2/20 0.48
DHODH Q02127 1/20 0.47
PLG P00747 1/20 0.47
PLAU P00749 1/20 0.47
PLAT P00750 1/20 0.47
KIF11 P52732 1/20 0.44
HSD17B1 P14061 2/20 0.43
HSD17B2 P37059 2/20 0.43
VNN1 O95497 1/20 0.43
SERPINE1 P05121 1/20 0.42
ABHD6 Q9BV23 1/20 0.41
GRIN2B Q13224 1/20 0.41
EPHX1 P07099 1/20 0.41
BACE1 P56817 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3023777 0.89 MAOB (0.50) MAOBTRPM8GPR52HDAC6HDAC11
SCHEMBL3453282 0.82 DHODH (0.42) MAOBTRPM8HDAC6HDAC11HDAC8
SCHEMBL3037000 0.81 DHODH (0.50) MAOBGPR52DHODHPLGPLAU
SCHEMBL3025882 0.80 HSD17B2 (0.61) AOC3PLGPLAUPLATHSD17B1
SCHEMBL3037021 0.79 MKNK1 (0.54) AOC3HSD17B1HSD17B2ABHD6
SCHEMBL3018101 0.77 DHODH (0.57) MAOBHDAC6HDAC11HDAC8DHODH
SCHEMBL3025997 0.76 HPGD (0.58) AOC3HSD17B2ABHD6
SCHEMBL1347829 0.76 BACE1 (0.54) MAOBGPR52HDAC6HDAC8DHODH
SCHEMBL3454136 0.75 PARP1 (0.46) MAOBTRPM8AOC3DHODHHSD17B1
SCHEMBL3727414 0.75 PLG (0.60) MAOBDHODHPLGPLAUPLAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US claimed
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS BRDT, AADAC, ACIN1 MAOB 1042/4885TRPM8 1626/4885GPR52 2353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.